375
Views
4
CrossRef citations to date
0
Altmetric
Drug Evaluation

Perspectives on a new prescription omega-3 fatty acid, icosapent ethyl, for hypertriglyceridemia

Pages 149-161 | Published online: 18 Jan 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Laurence S. Sperling & John R. Nelson. (2016) History and future of omega-3 fatty acids in cardiovascular disease. Current Medical Research and Opinion 32:2, pages 301-311.
Read now

Articles from other publishers (3)

Subhankar Chatterjee, Adrija Hajra, Dhrubajyoti Bandyopadhyay, Raktim K. Ghosh & Prakash C. Deedwania. (2020) Defining the Role of Icosapent Ethyl in Clinical Practice. American Journal of Cardiovascular Drugs 20:6, pages 517-524.
Crossref
Katherine Lyseng-Williamson, Paul L. McCormack & Esther S. Kim. (2016) Icosapent ethyl in hypertriglyceridaemia: a guide to its use. Drugs & Therapy Perspectives 32:3, pages 91-97.
Crossref
Esther S. Kim & Paul L. McCormack. (2014) Icosapent Ethyl: A Review of Its Use in Severe Hypertriglyceridemia. American Journal of Cardiovascular Drugs 14:6, pages 471-478.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.